Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Filings indexed 260 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2026-05-15 English
FORM 8-K
Regulatory Filings
2026-05-14 English
S-3 - Profound Medical Corp. (0001628808) (Filer)
Registration Form
2026-05-12 English
10-Q - Profound Medical Corp. (0001628808) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Profound Medical Corp. (0001628808) (Filer)
Regulatory Filings
2026-04-16 English
8-K - Profound Medical Corp. (0001628808) (Filer)
Regulatory Filings
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.